Regeneron Pharmaceuticals says it will acquire all of 23andMe's assets, including its Personal Genome Service, for $256M in a bankruptcy auction, closing in Q3 (Dean Seal/Wall Street Journal)

Dean Seal / Wall Street Journal:
Regeneron Pharmaceuticals says it will acquire all of 23andMe's assets, including its Personal Genome Service, for $256M in a bankruptcy auction, closing in Q3  —  Regeneron Pharmaceuticals said it will acquire substantially all of 23andMe's assets  —  Regeneron Pharmaceuticals …

Posted from: this blog via Microsoft Power Automate.

Daily Deals